116 related articles for article (PubMed ID: 36731295)
1. Synthesis of amide derivatives of 3-aryl-3H-benzopyrans as osteogenic agent concomitant with anticancer activity.
Singh S; Verma SC; Kumar V; Sharma K; Singh D; Khan S; Gupta N; Singh R; Khan F; Chanda D; Mishra DP; Singh D; Roy P; Gupta A
Bioorg Chem; 2023 Apr; 133():106380. PubMed ID: 36731295
[TBL] [Abstract][Full Text] [Related]
2. Induction of targeted osteogenesis with 3-aryl-2H-benzopyrans and 3-aryl-3H-benzopyrans: Novel osteogenic agents.
Gupta A; Ahmad I; Kureel J; Hasanain M; Pandey P; Singh S; John AA; Sarkar J; Singh D
J Steroid Biochem Mol Biol; 2016 Apr; 158():63-75. PubMed ID: 26807865
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of skeletal osteogenic progenitor cells to osteoblasts with 3,4-diarylbenzopyran based amide derivatives: Novel osteogenic agents.
Gupta A; Ahmad I; Kureel J; John AA; Sultan E; Chanda D; Agarwal NK; Alauddin ; Wahajuddin ; Prabhaker S; Verma A; Singh D
Eur J Med Chem; 2016 Oct; 121():82-99. PubMed ID: 27236065
[TBL] [Abstract][Full Text] [Related]
4. Induced osteoblast differentiation by amide derivatives of stilbene: The possible osteogenic agents.
Imran Ahamad M; Prakash R; John AA; Wani Z; Yadav D; Bawankule DU; Luqman S; Khan F; Singh D; Gupta A
Bioorg Med Chem Lett; 2020 Jun; 30(11):127138. PubMed ID: 32247734
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of substituted amide derivatives of C4-ageratochromene dimer analog.
Agarwal K; Gupta K; Sharma K; Khanka S; Singh S; Singh J; Trivedi L; Vasdev PG; Luqman S; Khan F; Singh D; Gupta A
Bioorg Med Chem Lett; 2021 Oct; 50():128340. PubMed ID: 34469711
[TBL] [Abstract][Full Text] [Related]
6. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
7. Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells.
Jiang C; Guo J; Wang Z; Xiao B; Lee HJ; Lee EO; Kim SH; Lu J
Breast Cancer Res; 2007; 9(6):R77. PubMed ID: 17986353
[TBL] [Abstract][Full Text] [Related]
8. A precisely substituted benzopyran targets androgen refractory prostate cancer cells through selective modulation of estrogen receptors.
Kumar R; Verma V; Sharma V; Jain A; Singh V; Sarswat A; Maikhuri JP; Sharma VL; Gupta G
Toxicol Appl Pharmacol; 2015 Mar; 283(3):187-97. PubMed ID: 25655200
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways.
Saxena R; Chandra V; Manohar M; Hajela K; Debnath U; Prabhakar YS; Saini KS; Konwar R; Kumar S; Megu K; Roy BG; Dwivedi A
PLoS One; 2013; 8(6):e66246. PubMed ID: 23840429
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Biological Investigation and Docking Study of Novel Chromen Derivatives as Anti-Cancer Agents.
Dube PN; Sakle NS; Dhawale SA; More SA; Mokale SN
Anticancer Agents Med Chem; 2019; 19(9):1150-1160. PubMed ID: 30848213
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 3,5-dihydroxy-7,8-dimethoxy-2-(4-methoxyphenyl)benzopyran-4-one derivatives as anticancer agents.
Singh S; Ahmad A; Raghuvanshi DS; Hasanain M; Agarwal K; Dubey V; Fatima K; Alam S; Sarkar J; Luqman S; Khan F; Tandon S; Gupta A
Bioorg Med Chem Lett; 2016 Nov; 26(21):5322-5327. PubMed ID: 27671497
[TBL] [Abstract][Full Text] [Related]
12. The anti-proliferative effect of 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H-benzo(b) pyran is potentiated via induction of estrogen receptor beta and p21 in human endometrial adenocarcinoma cells.
Fatima I; Saxena R; Kharkwal G; Hussain MK; Yadav N; Hajela K; Sankhwar PL; Dwivedi A
J Steroid Biochem Mol Biol; 2013 Nov; 138():123-31. PubMed ID: 23688837
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Investigation of the Role of Benzopyran Dihydropyrimidinone Hybrids in Cell Proliferation, Migration and Tumor Growth.
Dash AK; Nayak D; Hussain N; Mintoo MJ; Bano S; Katoch A; Mondhe DM; Goswami A; Mukherjee D
Anticancer Agents Med Chem; 2019; 19(2):276-288. PubMed ID: 30179143
[TBL] [Abstract][Full Text] [Related]
14. Optimisation of estrogen receptor subtype-selectivity of a 4-Aryl-4H-chromene scaffold previously identified by virtual screening.
Carr M; Knox AJS; Nevin DK; O'Boyle N; Wang S; Egan B; McCabe T; Twamley B; Zisterer DM; Lloyd DG; Meegan MJ
Bioorg Med Chem; 2020 Mar; 28(5):115261. PubMed ID: 31987694
[TBL] [Abstract][Full Text] [Related]
15. Development of potential anticancer agents and apoptotic inducers based on 4-aryl-4H chromene scaffold: Design, synthesis, biological evaluation and insight on their proliferation inhibition mechanism.
Elshemy HAH; Zaki MA; Mahmoud AM; Khan SI; Chittiboyina AG; Kamal AM
Bioorg Chem; 2022 Jan; 118():105475. PubMed ID: 34800886
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
[TBL] [Abstract][Full Text] [Related]
17. 2,3-Diaryl-2H-1-benzopyran derivatives interfere with classical and non-classical estrogen receptor signaling pathways, inhibit Akt activation and induce apoptosis in human endometrial cancer cells.
Fatima I; Chandra V; Saxena R; Manohar M; Sanghani Y; Hajela K; Negi MP; Sankhwar PL; Jain SK; Dwivedi A
Mol Cell Endocrinol; 2012 Jan; 348(1):198-210. PubMed ID: 21878365
[TBL] [Abstract][Full Text] [Related]
18. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, Characterization, Molecular Docking, In Vitro Biological Evaluation and In Vitro Cytotoxicity Study of Novel Thiazolidine-4-One Derivatives as Anti-Breast Cancer Agents.
Kadhim ZY; Alqaraghuli HGJ; Abd MT
Anticancer Agents Med Chem; 2021; 21(17):2397-2406. PubMed ID: 33797379
[TBL] [Abstract][Full Text] [Related]
20. Rational design and synthesis of 6-aryl-6H-benzo[c]chromenes as non-steroidal progesterone receptor antagonists for use against cancers.
Qin J; Qu S; Zhu K; Cheng Y; Pan G; Jing W; Liu X; Sun X; Liu L
Bioorg Med Chem; 2021 Feb; 32():116003. PubMed ID: 33461148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
